Literature DB >> 16650972

Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study.

Rafea Shaaban1, Sabine Kony, Fathi Driss, Bénédicte Leynaert, David Soussan, Isabelle Pin, Françoise Neukirch, Mahmoud Zureik.   

Abstract

Reduced pulmonary function is an important predictor of cardiovascular morbidity and mortality. The mechanisms underlying this association are unknown but may involve systemic inflammation. We assessed the cross-sectional and longitudinal relationships between C-reactive protein (CRP) levels and forced expiratory volume in 1s (FEV1) and its decline in the general population, over a period of 8.5 years. The analyzes were based on 531 subjects (mean age at baseline: 37+/-7 years, 50% women and 42% non-smokers), recruited at two French centers participating in the European Community Respiratory Health Survey. Lung function was expressed as a percentage of predicted FEV1. CRP was measured centrally, by means of a highly sensitive assay. In cross-sectional analysis, FEV1 as a % of predicted values was negatively associated with serum CRP concentration (P=0.002). Multivariate adjustment did not alter these results (P=0.002). In longitudinal analysis, annual FEV1 decline tended to increase from the lower to the upper tertile for baseline CRP concentration but the association was borderline significant (P=0.14). Mean values of annual FEV1 decline were 26+/-32, 31+/-32, and 34+/-32 ml/year for the lower, middle and upper tertiles of baseline CRP concentration, respectively, after adjusting for potential confounders (P=0.09). Changes in CRP levels during follow-up were associated with annual FEV1 decline. The mean annual FEV1 declines in subjects with increasing CRP, in those with stable CRP and in those with decreasing CRP were 36+/-31, 30+/-31 and 24+/-31 ml/year, respectively (P<0.001). These findings were not affected by adjustment for potential confounders (P=0.002). In conclusion, increases in CRP levels over time were associated with a steeper FEV1 decline.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650972     DOI: 10.1016/j.rmed.2006.03.027

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  57 in total

1.  Statin use reduces decline in lung function: VA Normative Aging Study.

Authors:  Stacey E Alexeeff; Augusto A Litonjua; David Sparrow; Pantel S Vokonas; Joel Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

2.  Systemic inflammation and decline in lung function in a general population: a prospective study.

Authors:  Andrew W Fogarty; Stuart Jones; John R Britton; Sarah A Lewis; Tricia M McKeever
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

3.  Systemic inflammation and progression of COPD.

Authors:  Jørgen Vestbo
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

4.  Decreased lung function is associated with vitamin D deficiency in apparently health, middle aged Koreans: the Kangbuk Samsung Health Study.

Authors:  Jonghoo Lee; Hye Kyeong Park; Min-Jung Kwon; Soo-Youn Ham; Si-Young Lim; Jae-Uk Song
Journal:  Eur J Clin Nutr       Date:  2020-09-15       Impact factor: 4.016

5.  Breathe Easy, Speak Easy: Pulmonary Function and Language Performance in Aging.

Authors:  Dalia Cahana-Amitay; Lewina O Lee; Avron Spiro; Martin L Albert
Journal:  Exp Aging Res       Date:  2018 Oct-Dec       Impact factor: 1.645

6.  Longitudinal change in FEV1 and FVC in chronic spinal cord injury.

Authors:  Kelly L Stolzmann; David R Gagnon; Robert Brown; Carlos G Tun; Eric Garshick
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

Review 7.  Associations between statins and COPD: a systematic review.

Authors:  Claudia C Dobler; Keith K Wong; Guy B Marks
Journal:  BMC Pulm Med       Date:  2009-07-12       Impact factor: 3.317

8.  Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Authors:  Francisco Garcia-Rio; Marc Miravitlles; Joan B Soriano; Luis Muñoz; Enric Duran-Tauleria; Guadalupe Sánchez; Víctor Sobradillo; Julio Ancochea
Journal:  Respir Res       Date:  2010-05-25

9.  Systemic inflammation in young adults is associated with abnormal lung function in middle age.

Authors:  Ravi Kalhan; Betty T Tran; Laura A Colangelo; Sharon R Rosenberg; Kiang Liu; Bharat Thyagarajan; David R Jacobs; Lewis J Smith
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

10.  Associations of IL6 polymorphisms with lung function decline and COPD.

Authors:  J-Q He; M G Foreman; K Shumansky; X Zhang; L Akhabir; D D Sin; S F P Man; D L DeMeo; A A Litonjua; E K Silverman; J E Connett; N R Anthonisen; R A Wise; P D Paré; A J Sandford
Journal:  Thorax       Date:  2009-04-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.